![Jelena Aleksic](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Jelena Aleksic is the Chief Business Officer and founder of PharmEnable Therapeutics Ltd, which was founded in 2016.
Dr. Aleksic is also the founder of GeneAdviser Ltd.
Posizioni attive di Jelena Aleksic
Società | Posizione | Inizio |
---|---|---|
Pharmenable Ltd.
![]() Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Fondatore | 01/06/2016 |
Precedenti posizioni note di Jelena Aleksic
Società | Posizione | Fine |
---|---|---|
GeneAdviser Ltd.
![]() GeneAdviser Ltd. BiotechnologyHealth Technology GeneAdviser Ltd. operates an online ordering platform for genetic test services. It enables doctors and their local laboratories to find and order tests for rare diseases, cancer treatment and personalized medicine. The company was founded by Jelena Aleksic and Robert Stojnic and is headquartered in Cambridge, the United Kingdom. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
GeneAdviser Ltd.
![]() GeneAdviser Ltd. BiotechnologyHealth Technology GeneAdviser Ltd. operates an online ordering platform for genetic test services. It enables doctors and their local laboratories to find and order tests for rare diseases, cancer treatment and personalized medicine. The company was founded by Jelena Aleksic and Robert Stojnic and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Pharmenable Ltd.
![]() Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Jelena Aleksic